Tumor angiogenesis, macrophages and mast cell microdensities in endometrioid endometrial carcinoma

Simionescu,Cristiana; Mărgăritescu,Claudiu; Stepan,Alex; Pirici,Daniel; Ciurea,Raluca; Cernea,Nicolae

doi:10.3892/ol.2013.1412

Tumor angiogenesis, macrophages and mast cell microdensities in endometrioid endometrial carcinoma

Authors:
- Cristiana Simionescu
- Claudiu Mărgăritescu
- Alex Stepan
- Daniel Pirici
- Raluca Ciurea
- Nicolae Cernea
View Affiliations

Affiliations: Department of Pathology, University of Medicine and Pharmacy of Craiova, Craiova 200349, Romania, Department of Histology, University of Medicine and Pharmacy of Craiova, Craiova 200349, Romania, Department of Obstetrics and Gynecology, University of Medicine and Pharmacy of Craiova, Craiova 200349, Romania
Published online on: June 18, 2013 https://doi.org/10.3892/ol.2013.1412
Pages: 415-420

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to observe and compare the values of microvessel density (MVD), mast cell microdensity (McMD) and macrophage microdensity (MphMD) in intratumoral areas compared with the advancing edges, and to assess any correlations between these values and the degree and stage of the neoplasia. The cases of 52 patients who were diagnosed with endometrial carcinoma between 2003 and 2011 were analyzed, the majority of which were in the first stage of the disease (44 cases). Double sequential immunohistochemistry and the hot‑spot counting method were used to assess the MVD (CD105+ MVD), McMD [tryptase+ (Try+) McMD] and MphMD (CD68+ MphMD) densities. The χ2 test, paired Student's t‑test and the Pearson correlation index were used to assess the significance of the results. A weak correlation was observed at the advancing edge only, between CD105+ MVD and Try+ McMD (P=0.039). No significant differences were identified in the analysis of CD105+ MVD, Try+ McMD and CD68+ MphMD, but wide variations in their distribution were observed. Depending on the tumor stage, CD105+ MVD exhibited an intratumoral, indirect correlation with Try+ McMD for stage IA (P=0.026) and II (P=0.013) tumors. CD105+ MVD presented an indirect correlation with CD68+ MphMD in stage IB tumors (P=0.016) and at the advancing edge for well‑differentiated tumors (P=0.027). An analysis of the correlation between CD68+ MphMD and Try+ McMD indicated that the intratumoral levels of CD68+ MphMD were directly proportional with the Try+ McMD values in well‑differentiated (P=0.005) and stage II (P=0.012) tumors, while at the front of the invasion, this correlation was indirect (P=0.010) in stage II tumors. In endometrioid endometrial carcinoma (EEC), angiogenesis is at its most active at the advancing edge of the tumor, where mast cells play a pro‑angiogenic role.

View Figures

View References

1.	Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
2.	Sherman ME: Theories of endometrial carcinogenesis: a multi-disciplinary approach. Mod Pathol. 13:295–308. 2000. View Article : Google Scholar : PubMed/NCBI
3.	Lax SF: Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch. 444:213–223. 2004. View Article : Google Scholar : PubMed/NCBI
4.	Bansal N, Yendluri V and Wenham RM: The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control. 16:8–13. 2009.PubMed/NCBI
5.	Theoharides TC and Conti P: Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol. 25:235–241. 2004. View Article : Google Scholar : PubMed/NCBI
6.	Crowther M, Brown NJ, Bishop ET and Lewis CE: Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol. 70:478–490. 2001.PubMed/NCBI
7.	Kataki A, Scheid P, Piet M, Marie B, Martinet N, Martinet Y and Vignaud JM: Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. J Lab Clin Med. 140:320–328. 2002. View Article : Google Scholar : PubMed/NCBI
8.	Lewis CE and Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
9.	Murdoch C, Giannoudis A and Lewis CE: Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood. 104:2224–2234. 2004. View Article : Google Scholar : PubMed/NCBI
10.	Murdoch C, Muthana M and Lewis CE: Hypoxia regulates macrophage functions in inflammation. J Immunol. 175:6257–6263. 2005. View Article : Google Scholar : PubMed/NCBI
11.	Condeelis J and Pollard JW: Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 124:263–266. 2006. View Article : Google Scholar : PubMed/NCBI
12.	Dirkx AE, Oude Egbrink MG, Wagstaff J and Griffioen AW: Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J Leukoc Biol. 80:1183–1196. 2006. View Article : Google Scholar : PubMed/NCBI
13.	Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev. 4:71–78. 2004. View Article : Google Scholar : PubMed/NCBI
14.	Ribatti D and Crivellato E: The controversial role of mast cells in tumor growth. Int Rev Cell Mol Biol. 275:89–131. 2009. View Article : Google Scholar : PubMed/NCBI
15.	Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG and Gruber BL: Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest. 99:2691–2700. 1997. View Article : Google Scholar
16.	Silverberg SG, Kurman RJ, Nogales F, Mutter GL, Kubik-Huch RA and Tavassoli FA: Tumors of the uterine corpus. Epithelial tumors and related lesions. WHO Classification of Tumors: Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Tavassoli FA and Devilee P: IARC Press; Lyon, France: pp. 221–232. 2003
17.	Weidner N, Carroll PR, Flax J, Blumenfeld W and Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 143:401–409. 1993.PubMed/NCBI
18.	Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6. 1990. View Article : Google Scholar : PubMed/NCBI
19.	Hanahan D and Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:353–364. 1996. View Article : Google Scholar : PubMed/NCBI
20.	Bergers G and Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003. View Article : Google Scholar
21.	Ribatti D, Vacca A, Marzullo A, Nico B, Ria R, Roncali L and Dammacco F: Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin’s lymphomas. Int J Cancer. 85:171–175. 2000.PubMed/NCBI
22.	Hashimoto I, Kodama J, Seki N, Hongo A, Miyagi Y, Yoshinouchi M and Kudo T: Macrophage infiltration and angiogenesis in endometrial cancer. Anticancer Res. 20:4853–4856. 2000.PubMed/NCBI
23.	Gargett CE, Lederman F, Heryanto B, Gambino LS and Rogers PA: Focal vascular endothelial growth factor correlates with angiogenesis in human endometrium. Role of intravascular neutrophils. Hum Reprod. 16:1065–1075. 2001. View Article : Google Scholar : PubMed/NCBI
24.	Ribatti D, Finato N, Crivellato E, Marzullo A, Mangieri D, Nico B, Vacca A and Beltrami CA: Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am J Obstet Gynecol. 193:1961–1965. 2005. View Article : Google Scholar : PubMed/NCBI
25.	Goksu Erol AY, Tokyol C, Ozdemir O, Yilmazer M, Arioz TD and Aktepe F: The role of mast cells and angiogenesis in benign and malignant neoplasms of the uterus. Pathol Res Pract. 207:618–622. 2011.PubMed/NCBI
26.	Cinel L, Aban M, Basturk M, Ertunc D, Arpaci R, Dilek S and Camdeviren H: The association of mast cell density with myometrial invasion in endometrial carcinoma: a preliminary report. Pathol Res Pract. 205:255–258. 2009. View Article : Google Scholar : PubMed/NCBI
27.	Pansrikaew P, Cheewakriangkrai C, Taweevisit M, Khunamornpong S and Siriaunkgul S: Correlation of mast cell density, tumor angiogenesis, and clinical outcomes in patients with endometrioid endometrial cancer. Asian Pac J Cancer Prev. 11:623–626. 2010.
28.	Espinosa I, José Carnicer M, Catasus L, Canet B, D’angelo E, Zannoni GF and Prat J: Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role. Am J Surg Pathol. 34:1708–1714. 2010.
29.	Soeda S, Nakamura N, Ozeki T, Nishiyama H, Hojo H, Yamada H, Abe M and Sato A: Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma. Gynecol Oncol. 109:122–128. 2008. View Article : Google Scholar
30.	Salvesen HB and Akslen LA: Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas. Int J Cancer. 84:538–543. 1999. View Article : Google Scholar
31.	Ohno S, Ohno Y, Suzuki N, Kamei T, Koike K, Inagawa H, Kohchi C, Soma G and Inoue M: Correlation of histological localization of tumor-associated macrophages with clinico-pathological features in endometrial cancer. Anticancer Res. 24:3335–3342. 2004.PubMed/NCBI
32.	Erol AY and Ozdemir O: Do mast cell phenotypes play a role in concomitantly increased microvessel density and progression of non-small cell lung cancer? Hum Pathol. 42:1056–1057. 2011. View Article : Google Scholar : PubMed/NCBI
33.	Saad RS, Jasnosz KM, Tung MY and Silverman JF: Endoglin (CD105) expression in endometrial carcinoma. Int J Gynecol Pathol. 22:248–253. 2003. View Article : Google Scholar : PubMed/NCBI
34.	Salvesen HB, Gulluoglu MG, Stefansson I and Akslen LA: Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas. APMIS. 111:1011–1018. 2003. View Article : Google Scholar : PubMed/NCBI
35.	Ribatti D, Nico B, Finato N and Crivellato E: Tryptase-positive mast cells and CD8-positive T cells in human endometrial cancer. Pathol Int. 61:442–444. 2011. View Article : Google Scholar : PubMed/NCBI